EPISODE · May 7, 2026 · 15 MIN
White House Order Pushes FDA to Fast-Track Serious Mental Health Treatments
from 1nessAgency Insights
The FDA's announcement names specific companies, specific compounds, and specific conditions. Three firms received national priority vouchers for psilocybin studies targeting treatment-resistant depression and major depressive disorder, and for methylone targeting PTSD [1]. DemeRx NB received cleara
What this episode covers
The FDA's announcement names specific companies, specific compounds, and specific conditions. Three firms received national priority vouchers for psilocybin studies targeting treatment-resistant depression and major depressive disorder, and for methylone targeting PTSD [1]. DemeRx NB received cleara
NOW PLAYING
White House Order Pushes FDA to Fast-Track Serious Mental Health Treatments
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.